These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37750986)

  • 1. Monotropein Induced Apoptosis and Suppressed Cell Cycle Progression in Colorectal Cancer Cells.
    Gao Q; Li L; Zhang QM; Sheng QS; Zhang JL; Jin LJ; Shang RY
    Chin J Integr Med; 2024 Jan; 30(1):25-33. PubMed ID: 37750986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lycorine inhibits cell proliferation, migration and invasion, and primarily exerts
    Zhang P; Yuan X; Yu T; Huang H; Yang C; Zhang L; Yang S; Luo X; Luo J
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
    Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
    J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Berbamine dihydrochloride suppresses the progression of colorectal cancer via RTKs/Akt axis.
    Liu L; Liang D; Zheng Q; Zhao M; Lv R; Tang J; Chen N
    J Ethnopharmacol; 2023 Mar; 303():116025. PubMed ID: 36496042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation.
    Lu S; Sun X; Zhou Z; Tang H; Xiao R; Lv Q; Wang B; Qu J; Yu J; Sun F; Deng Z; Tian Y; Li C; Yang Z; Yang P; Rao B
    Front Immunol; 2023; 14():1235575. PubMed ID: 37799727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isobavachalcone isolated from
    Li Y; Qin X; Li P; Zhang H; Lin T; Miao Z; Ma S
    Drug Des Devel Ther; 2019; 13():1449-1460. PubMed ID: 31118579
    [No Abstract]   [Full Text] [Related]  

  • 7. Network Pharmacology-based Prediction and Verification of Shikonin for Treating Colorectal Cancer.
    Wang Z; Cui Q; Shi L; Zhang M; Song P; Duan D; Guo W
    Recent Pat Anticancer Drug Discov; 2022; 17(3):297-311. PubMed ID: 34951580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voacamine is a novel inhibitor of EGFR exerting oncogenic activity against colorectal cancer through the mitochondrial pathway.
    Chen Y; Yang J; Zuo Y; Zhang C; Pu Y; Ren Q; Li X; Huang Y; Huang H; Yang H; You O; Xia X; Lu A; Shi S; Deng Y; Lu J
    Pharmacol Res; 2022 Oct; 184():106415. PubMed ID: 36029932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-elemene Suppresses Migration of Esophageal Squamous Cell Carcinoma by Modulating Expression of MMP9 through the PI3K/Akt/NF-κB Pathway.
    Liang Y; Li S
    Comb Chem High Throughput Screen; 2023; 26(13):2304-2320. PubMed ID: 36872359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of REG Iα Enhances the Sensitivity to 5-Fluorouracil of Colorectal Cancer Cells via Cyclin D1/CDK4 Pathway and BAX/BCL-2 Pathways.
    Wang Y; Liu X; Liu J; Zhang T
    Cancer Biother Radiopharm; 2019 Aug; 34(6):362-370. PubMed ID: 30973271
    [No Abstract]   [Full Text] [Related]  

  • 11. Discovery of a nitroaromatic nannocystin with potent in vivo anticancer activity against colorectal cancer by targeting AKT1.
    Zhang H; Xie F; Yuan XY; Dai XT; Tian YF; Sun MM; Yu SQ; Cai JY; Sun B; Zhang WC; Shan CL
    Acta Pharmacol Sin; 2024 May; 45(5):1044-1059. PubMed ID: 38326625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reg4-induced mitogenesis involves Akt-GSK3β-β-Catenin-TCF-4 signaling in human colorectal cancer.
    Bishnupuri KS; Sainathan SK; Bishnupuri K; Leahy DR; Luo Q; Anant S; Houchen CW; Dieckgraefe BK
    Mol Carcinog; 2014 Feb; 53 Suppl 1(0 1):E169-80. PubMed ID: 24151146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMP-kinase inhibitor dorsomorphin reduces the proliferation and migration behavior of colorectal cancer cells by targeting the AKT/mTOR pathway.
    Ghanaatgar-Kasbi S; Amerizadeh F; Rahmani F; Hassanian SM; Khazaei M; Ferns GA; Avan A
    IUBMB Life; 2019 Dec; 71(12):1929-1936. PubMed ID: 31359579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RA-XII, a bicyclic hexapeptidic glucoside isolated from Rubia yunnanensis Diels, exerts antitumor activity by inhibiting protective autophagy and activating Akt-mTOR pathway in colorectal cancer cells.
    Wang J; Wang J; Li L; Feng L; Wang YR; Wang Z; Tan NH
    J Ethnopharmacol; 2021 Feb; 266():113438. PubMed ID: 33017635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymol Isolated from
    Zeng Q; Che Y; Zhang Y; Chen M; Guo Q; Zhang W
    Drug Des Devel Ther; 2020; 14():2535-2547. PubMed ID: 32669835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of allograft inflammatory factor-1 in regulating the proliferation, migration and apoptosis of colorectal cancer cells].
    Ai XL; Yao F; Wang XJ; Duan DB; Li K; Hu ZY; Yin G; Wang M; Wu BY
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 May; 38(5):511-519. PubMed ID: 29891445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of GRHL2 inhibited proliferation and induced apoptosis of colorectal cancer by suppressing the PI3K/Akt pathway.
    Hu F; He Z; Sun C; Rong D
    Gene; 2019 Jun; 700():96-104. PubMed ID: 30917932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of colorectal cancer tumorigenesis by ursolic acid and doxorubicin is mediated by targeting the Akt signaling pathway and activating the Hippo signaling pathway.
    Hu D; Meng RY; Nguyen TV; Chai OH; Park BH; Lee JS; Kim SM
    Mol Med Rep; 2023 Jan; 27(1):. PubMed ID: 36382656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Glut1 gene silencing on proliferation, differentiation, and apoptosis of colorectal cancer cells by targeting the TGF-β/PI3K-AKT-mTOR signaling pathway.
    Wu XL; Wang LK; Yang DD; Qu M; Yang YJ; Guo F; Han L; Xue J
    J Cell Biochem; 2018 Feb; 119(2):2356-2367. PubMed ID: 28884839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective β2-AR Blockage Suppresses Colorectal Cancer Growth Through Regulation of EGFR-Akt/ERK1/2 Signaling, G1-Phase Arrest, and Apoptosis.
    Chin CC; Li JM; Lee KF; Huang YC; Wang KC; Lai HC; Cheng CC; Kuo YH; Shi CS
    J Cell Physiol; 2016 Feb; 231(2):459-72. PubMed ID: 26189563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.